Journal list menu
Export Citations
Download PDFs
Issue Information
Images in Haematology
no
Chédiak–Higashi syndrome approached by several different microscopy imaging technologies
- Page: 1001
- First Published: 03 April 2020
no
Amyloid purpura of the breasts in a patient with systemic AL amyloidosis
- Page: 1002
- First Published: 22 March 2020
Commentary
Free Access
free
Venetoclax: the first anti-myeloma agent with a reliable biomarker
- Pages: 1003-1005
- First Published: 03 February 2020
Free Access
free
A key step towards setting a benchmark for tackling transplant-associated thrombotic microangiopathy
- Pages: 1006-1009
- First Published: 12 February 2020
Free Access
free
Monoclonal gammopathy of undetermined significance in medical hospital admissions – a new strategy for screening?
- Pages: 1010-1011
- First Published: 18 February 2020
Free Access
free
ERFE regulation in sickle cell disease: complex but promising
- Pages: 1012-1013
- First Published: 24 February 2020
Free Access
free
Cognitive deficit in sickle cell disease: Is hydroxyurea part of the story?
- Pages: 1014-1015
- First Published: 24 February 2020
How We Manage
no
How we manage adults with myelodysplastic syndrome
- Pages: 1016-1027
- First Published: 30 September 2019
Emergencies in Haematology
no
Central nervous system emergencies in haematological malignancies
- Pages: 1028-1037
- First Published: 04 September 2019
COVID-19
Free Access
free
Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic
- Pages: 1038-1043
- First Published: 06 May 2020
Short Reports
Free Access
free
Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis
- Pages: 1050-1052
- First Published: 18 April 2020
Free Access
free
Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19
- Pages: 1053-1054
- First Published: 30 April 2020
Free Access
free
Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukaemia
- Pages: 1054-1056
- First Published: 05 May 2020
Free Access
free
Thrombocytopenia as an initial manifestation of COVID-19; case series and literature review
- Pages: 1057-1058
- First Published: 05 May 2020
Free Access
free
More on: ‘COVID-19 coagulopathy in Caucasian patients’
- Pages: 1059-1060
- First Published: 11 May 2020
Free Access
free
More on COVID-19 coagulopathy in Caucasian patients
- Pages: 1060-1061
- First Published: 12 May 2020
Free Access
free
Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date
- Pages: 1062-1063
- First Published: 05 May 2020
Haematological Malignancy - Clinical
no
Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression
- Pages: 1064-1073
- First Published: 04 March 2020
Open Access
oa
Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma
- Pages: 1074-1082
- First Published: 28 February 2020
no
Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century – a Swedish lymphoma register study
- Pages: 1083-1092
- First Published: 17 February 2020
Open Access
oa
Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990–2015
- Pages: 1093-1106
- First Published: 06 February 2020
no
Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000–2016
- Pages: 1107-1118
- First Published: 23 February 2020
no
Pembrolizumab with R-CHOP in previously untreated diffuse large B-cell lymphoma: potential for biomarker driven therapy
- Pages: 1119-1126
- First Published: 06 February 2020
no
The prevalence and significance of monoclonal gammopathy of undetermined significance in acute medical admissions
- Pages: 1127-1135
- First Published: 30 January 2020
Short Report
Open Access
oa
Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myeloma
- Pages: 1136-1140
- First Published: 03 February 2020
no
Correction of Bcl-x splicing improves responses to imatinib in chronic myeloid leukaemia cells and mouse models
- Pages: 1141-1150
- First Published: 19 March 2020
no
Lycorine targets multiple myeloma stem cell-like cells by inhibition of Wnt/β-catenin pathway
- Pages: 1151-1164
- First Published: 13 March 2020
Short Report
no
Genomic evolution of ibrutinib-resistant clones in Waldenström macroglobulinaemia
- Pages: 1165-1170
- First Published: 27 February 2020
Transplantation
no
Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy
- Pages: 1171-1181
- First Published: 02 March 2020
Platelets, Haemostasis and Thrombosis
Open Access
oa
Product type and the risk of inhibitor development in nonsevere haemophilia A patients: a case‒control study
- Pages: 1182-1191
- First Published: 22 March 2020
Haemoglobinopathies
no
Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease
- Pages: 1192-1203
- First Published: 26 February 2020
Short Report
no
Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease
- Pages: 1204-1209
- First Published: 06 February 2020
Correspondence
Free Access
free
Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression
- Pages: e222-e224
- First Published: 05 May 2020
Free Access
free
Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID-19 pandemic
- Pages: e224-e227
- First Published: 05 May 2020
Free Access
free
Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily
- Pages: e227-e230
- First Published: 05 May 2020
Free Access
free
An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia
- Pages: e231-e234
- First Published: 21 April 2020
Free Access
free
Immune escape by loss of heterozygosis of HLA genes facilitated the transmission of diffuse large B cell lymphoma from mother to offspring
- Pages: e234-e237
- First Published: 17 April 2020
Free Access
free
De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes
- Pages: e237-e240
- First Published: 27 April 2020
Free Access
free
High-level induction of fetal haemoglobin by pomalidomide in β-thalassaemia/HbE erythroid progenitor cells
- Pages: e240-e245
- First Published: 02 May 2020
Free Access
free
Clinical and biological correlates of the expression of select Polycomb complex genes in Brazilian children with acute promyelocytic leukaemia
- Pages: e245-e248
- First Published: 21 April 2020
Free Access
free
LyRIC indeterminate response and Immune-mediated pseudoprogression of diffuse large B-cell lymphoma following polatuzumab-based salvage therapy
- Pages: e248-e251
- First Published: 27 April 2020
Free Access
free
Venetoclax and decitabine for relapsed paediatric myelodysplastic syndrome-related acute myeloid leukaemia with complex aberrant karyotype after second stem cell transplantation
- Pages: e251-e254
- First Published: 28 April 2020
Free Access
free
Theranostic drug test incorporating the bone-marrow microenvironment can predict the clinical response of acute myeloid leukaemia to chemotherapy
- Pages: e254-e258
- First Published: 28 April 2020
Free Access
free
Addition of low-dose decitabine to bortezomib and dexamethasone as second-line therapy in multiple myeloma
- Pages: e258-e262
- First Published: 28 April 2020
Free Access
free
Progressive increase in FIX level in males with haemophilia B Leyden and c.35G > A mutation in early childhood not related to androgen effect
- Pages: e262-e265
- First Published: 28 April 2020